Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 243

1.

Duloxetine treatment for role functioning improvement in generalized anxiety disorder: three independent studies.

Endicott J, Russell JM, Raskin J, Detke MJ, Erickson J, Ball SG, Marciniak M, Swindle RW.

J Clin Psychiatry. 2007 Apr;68(4):518-24. Erratum in: J Clin Psychiatry. 2007 May;68(5):806. J Clin Psychiatry. 2007 Apr;68(4):518.

PMID:
17474806
[PubMed - indexed for MEDLINE]
2.

Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment.

Pollack MH, Endicott J, Liebowitz M, Russell J, Detke M, Spann M, Ball S, Swindle R.

J Psychiatr Res. 2008 Oct;42(12):1042-9. doi: 10.1016/j.jpsychires.2007.11.006. Epub 2008 Jan 24.

PMID:
18221755
[PubMed - indexed for MEDLINE]
3.

Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

Carter NJ, McCormack PL.

CNS Drugs. 2009;23(6):523-41. doi: 10.2165/00023210-200923060-00006. Review.

PMID:
19480470
[PubMed - indexed for MEDLINE]
4.

Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.

Rynn M, Russell J, Erickson J, Detke MJ, Ball S, Dinkel J, Rickels K, Raskin J.

Depress Anxiety. 2008;25(3):182-9.

PMID:
17311303
[PubMed - indexed for MEDLINE]
5.

Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials.

Allgulander C, Hartford J, Russell J, Ball S, Erickson J, Raskin J, Rynn M.

Curr Med Res Opin. 2007 Jun;23(6):1245-52. Epub 2007 Apr 25.

PMID:
17559726
[PubMed - indexed for MEDLINE]
6.

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.

Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ.

Arthritis Rheum. 2004 Sep;50(9):2974-84.

PMID:
15457467
[PubMed - indexed for MEDLINE]
Free Article
7.

Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials.

Kornstein SG, Wohlreich MM, Mallinckrodt CH, Watkin JG, Stewart DE.

J Clin Psychiatry. 2006 May;67(5):761-70.

PMID:
16841626
[PubMed - indexed for MEDLINE]
8.

Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies.

Davidson J, Allgulander C, Pollack MH, Hartford J, Erickson JS, Russell JM, Perahia D, Wohlreich MM, Carlson J, Raskin J.

Hum Psychopharmacol. 2008 Aug;23(6):519-26. doi: 10.1002/hup.949.

PMID:
18478624
[PubMed - indexed for MEDLINE]
9.

Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms.

Russell JM, Weisberg R, Fava M, Hartford JT, Erickson JS, D'Souza DN.

Depress Anxiety. 2008;25(7):E1-11.

PMID:
17587217
[PubMed - indexed for MEDLINE]
10.

Duloxetine for the treatment of major depressive disorder: a closer look at efficacy and safety data across the approved dose range.

Mallinckrodt CH, Prakash A, Andorn AC, Watkin JG, Wohlreich MM.

J Psychiatr Res. 2006 Jun;40(4):337-48. Epub 2005 Nov 4.

PMID:
16271726
[PubMed - indexed for MEDLINE]
11.

Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial.

Hartford J, Kornstein S, Liebowitz M, Pigott T, Russell J, Detke M, Walker D, Ball S, Dunayevich E, Dinkel J, Erickson J.

Int Clin Psychopharmacol. 2007 May;22(3):167-74.

PMID:
17414743
[PubMed - indexed for MEDLINE]
12.

Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.

Nierenberg AA, Greist JH, Mallinckrodt CH, Prakash A, Sambunaris A, Tollefson GD, Wohlreich MM.

Curr Med Res Opin. 2007 Feb;23(2):401-16.

PMID:
17288694
[PubMed - indexed for MEDLINE]
13.

Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpoint.

Pollack MH, Kornstein SG, Spann ME, Crits-Christoph P, Raskin J, Russell JM.

J Psychiatr Res. 2008 Oct;42(14):1176-84. doi: 10.1016/j.jpsychires.2008.02.002. Epub 2008 Mar 17.

PMID:
18348888
[PubMed - indexed for MEDLINE]
14.

Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial.

Nicolini H, Bakish D, Duenas H, Spann M, Erickson J, Hallberg C, Ball S, Sagman D, Russell JM.

Psychol Med. 2009 Feb;39(2):267-76. doi: 10.1017/S0033291708003401. Epub 2008 May 19.

PMID:
18485261
[PubMed - indexed for MEDLINE]
15.

Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder.

Delgado PL, Brannan SK, Mallinckrodt CH, Tran PV, McNamara RK, Wang F, Watkin JG, Detke MJ.

J Clin Psychiatry. 2005 Jun;66(6):686-92.

PMID:
15960560
[PubMed - indexed for MEDLINE]
16.

Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.

Pollack M, Kinrys G, Krystal A, McCall WV, Roth T, Schaefer K, Rubens R, Roach J, Huang H, Krishnan R.

Arch Gen Psychiatry. 2008 May;65(5):551-62. doi: 10.1001/archpsyc.65.5.551.

PMID:
18458207
[PubMed - indexed for MEDLINE]
17.

A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder.

Allgulander C, Nutt D, Detke M, Erickson J, Spann M, Walker D, Ball S, Russell J.

J Psychopharmacol. 2008 Jun;22(4):417-25. doi: 10.1177/0269881108091588.

PMID:
18635722
[PubMed - indexed for MEDLINE]
18.

Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse.

Hollander E, Stein DJ, Fineberg NA, Marteau F, Legault M.

J Clin Psychiatry. 2010 Jun;71(6):784-92. doi: 10.4088/JCP.09m05911blu. Epub 2010 May 4.

PMID:
20492845
[PubMed - indexed for MEDLINE]
19.

Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder.

Clayton A, Kornstein S, Prakash A, Mallinckrodt C, Wohlreich M.

J Sex Med. 2007 Jul;4(4 Pt 1):917-29.

PMID:
17627739
[PubMed - indexed for MEDLINE]
20.

Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.

Brecht S, Courtecuisse C, Debieuvre C, Croenlein J, Desaiah D, Raskin J, Petit C, Demyttenaere K.

J Clin Psychiatry. 2007 Nov;68(11):1707-16.

PMID:
18052564
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk